Baseimmune

Discovery Platform

We combine scientific expertise with our proprietary AI-platform to generate mutation-resistant vaccines.

Data

Genomic, Proteomic, Epidemiological & Immunological

AI Generate

Multi-target de novo

antigen generation

Validate

Validated in our

laboratory

Modelling pathogen evolution and immune response to generate vaccines against emerging and complex pathogens that have been failed by traditional approaches.

Broader coverage

Maintaining coverage

when pathogens mutate

Enabling multi-strain and multi-species vaccines

Enabling longer-lasting vaccines through predicting and targeting pathogen mutations

Backed by exceptional science

Team

Founded in 2019 by a technical team of vaccine and software developers, Baseimmune is accelerating discovery of novel and cross-protective vaccines. Our founders pioneered the use of computational approaches to design cross-protective vaccines against various infectious diseases while at the Jenner Institute University of Oxford with two candidates in clinical trials.

Leadership

Joshua Blight

Ariane C. Gomes

Phillip Kemlo

Co-founder, CEO

Co-founder, CSO

Co-founder, CTO

Board of Directors

Jamie

Macfarlane

Creator Fund

Hussein

Kanji

Hoxton Ventures

Alex

Wilson

IQ Capital

Joshua

Blight

Baseimmune

Ariane

Gomes

Baseimmune

Phillip

Kemlo

Baseimmune

Careers

Join the team to harness the power of our computational platform to design and create variant-proof vaccines. Check our careers page for available positions.

See Opportunities

Working with world-class